Abingworth Management Overview

  • Investor Type
  • Venture Capital
  • Status
  • Active
  • Professionals
  • 13
Professionals
  • Investments
  • 235
  • Portfolio
  • 29
  • Exits
  • 148
Exits

Abingworth Management General Information

Description

Founded in 1973, Abingworth Management is a venture capital firm headquartered in London, United Kingdom. The firm seeks to invest in life science companies across biotherapeutics, small molecules, nucleic acid therapeutics, vaccines, specialty pharma, technologies, medical devices, diagnostics, instrumentation, and software sectors.

Contact Information

Year Founded
1973
Investor Status
Actively Seeking New Investments
Primary Investor Type
Venture Capital
Other Investor Types
Growth/Expansion
Primary Office
  • 38 Jermyn Street
  • London SW1Y 6DN
  • England, United Kingdom
+44 020 0000 0000

Abingworth Management Investments & Acquisitions (235)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Adaptate Biotherapeutics 19-Apr-2021 Early Stage VC 0000 Drug Discovery Startup 0000000 000000
00 000000000000000 19-Mar-2021 0000 0000 Biotechnology Generating Revenue/Not Profitable
00000 16-Mar-2021 00000 00000 000.00 Drug Discovery Generating Revenue/Not Profitable 000000 0000000000 00.0
0000 000000000000 19-Jan-2021 00000 00000 0000 Drug Discovery Clinical Trials - General 0000 000 000000
00000000 000000000 07-Jan-2021 00000 00000 00000 Drug Discovery Startup
000000 00000000000 16-Dec-2020 00000 00000 0000 Drug Discovery Clinical Trials - General 000000 00000 00.0
000 000 29-Oct-2020 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1 00000 000000000 00.0
00000000 000000000 26-Oct-2020 00000 00000 00000 Drug Discovery Startup
NuCana 21-Sep-2020 PIPE 000.00 Drug Discovery Clinical Trials - General
Nido Biosciences 08-Sep-2020 Early Stage VC 000.00 Drug Discovery Stealth
You’re viewing 10 of 235 investments and acquisitions. Get the full list »
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Abingworth Management Exits (148)

Company Name Exit Date Exit Type Exit Size
Reneo 09-Apr-2021 IPO 000.00
000000 00000000000 11-Mar-2021 000 00 00000000
000000 00000000000 09-Oct-2020 000 0000
0000000 12-Jun-2020 000 00000
0000000 05-Feb-2020 000000000000000000
0000000 0000000000 09-Jan-2020 000000000000000000 000.00
0000000 0000000000 25-Oct-2019 000 00000
00000 000000000000 31-Jul-2019 000000000000000000 000.00
Personalis 20-Jun-2019 IPO 00000
IFM Tre 07-May-2019 Merger/Acquisition 00.000
You’re viewing 10 of 148 exits. Get the full list »

Abingworth Management Fund Performance

Fund Name Vintage Size Dry Powder DPI RVPI TVPI IRR

This information is available in the PitchBook Platform. To explore Abingworth Management‘s full profile, request access.

Request a free trial

Abingworth Management Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Abingworth Management Team (40)

Name Title Deals Funds Boards Office
Neil Cooper Chief Financial Officer London, United Kingdom
Timothy Haines Managing Partner & Chairman 00 0 0 London, United Kingdom
Genghis Lloyd-Harris Ph.D Managing Partner 0 0 0 London, United Kingdom
Kurt von Emster Managing Partner 00 0 0 Menlo Park, CA
John Heard JD General Counsel & Partner London, United Kingdom
You’re viewing 5 of 40 team members. Get the full list »

Abingworth Management Co-Investors (84)

Name With Exits Lead Partner Series Industry
Atlas Venture 4 0 0 Series chart Industry bar
Citadel (Hedge Fund) 0 0 Series chart Industry bar
Omega Funds 0 0 0 Series chart Industry bar
OrbiMed 0 0 0 Series chart Industry bar
Versant Ventures 0 0 Series chart Industry bar
You’re viewing 5 of 84 co-investors. Get the full list »